Solid composition comprising iron for use in iron deficient conditions
An iron-based composition is described. The composition can be used in conditions of total or relative iron deficiency. In particular, a solid composition is described, preferably in the form of powder or granules, for use in the treatment of disorders or diseases related to or derived from an iron deficiency. The composition is suitable for pediatric subjects, adolescents, athletes, men, women, pregnant women and elderly. Finally, a process for preparing the solid composition is also described.
1. A solid composition comprising an iron (Ill) salt, said iron (Ill) salt being ferric pyrophosphate in an amount from 30% to 70% by weight, sucrose esters or sucresters E473, wherein said sucrose esters or sucresters E473 are in an amount from 10% to 30% by weight, and a non-hydrolyzed lecithin wherein said lecithin is in an amount from 0.1% to 1.5% by weight.
2. The composition according to claim 1 , wherein said composition further comprises a gelatinized or pregelatinized starch.
3. The composition according to claim 1 , wherein said non-hydrolyzed lecithin is a lecithin E322 and is selected from the group consisting of the maize, sunflower and soya lecithin.
4. The composition according to claim 1 , wherein said sucrose ester or sucrester and said non-hydrolyzed lecithin are in the composition in a weight ratio from 25:1 to 20:1.
5. The composition according to claim 2 , wherein said gelatinized or pregelatinized starch is selected from the group consisting of rice starch and maize starch; said starch is in an amount from 15 to 40% by weight.
6. The composition according to claim 1 , comprising a ferric pyrophosphate in an amount from 50 to 55% by weight; a sunflower lecithin in an amount from 0.5 to 0.8% by weight; sucrester E473 in an amount from 16 to 20% by weight; and gelatinized or pregelatinized rice starch in an amount from 25 to 30% by weight.
7. A supplement product or a medical device or a pharmaceutical composition for oral use comprising the solid composition according to claim 1 for use in the treatment of iron deficiency in pediatric subjects, adolescents, athletes, men, women, pregnant women and elderly.
8. A method for preparing the solid composition of claim 1 , comprising:
coating or encapsulating the iron (Ill) salt with said sucrose esters or sucresters E473 and the non-hydrolyzed lecithin.
9. The method of claim 8 , wherein the coating or encapsulating comprises:
contacting the iron (Ill) salt in solid state with said lecithin to produce a coated iron (Ill) salt with lecithin uniformly arranged over the iron (Ill) salt; and
contacting the coated iron (Ill) salt with said sucrose ester or sucrester E473 and optionally a vegetable starch.
10. The method of claim 8 , wherein the solid composition has an iron (Ill) salt content from 60 mg/g to 140 mg/g.
11. The method of claim 8 , wherein said sucrose ester or sucrester and said non-hydrolyzed lecithin are in a weight ratio from 20:1 to 15:1 and wherein the solid composition optionally comprises: a starch in an amount from 15 to 40%, said starch being rice starch or maize starch.
12. The method according to claim 8 , wherein the non-hydrolyzed lecithin is selected from the group consisting of sunflower, maize and soya lecithin.
13. The method according to claim 8 , wherein the lecithin is sunflower lecithin E322 in powder form.
14. The composition according to claim 1 , wherein the ferric pyrophosphate is in an amount from 40 to 60% by weight.
15. The composition according to claim 1 , wherein said sucrose esters or sucresters E473 are in an amount from 15% to 25% by weight.
16. The composition according to claim 1 , wherein said lecithin is in an amount from 0.4 to 1% by weight.
17. The composition according to claim 1 , wherein said sucrose ester or sucrester and said non-hydrolyzed lecithin are in the composition in a weight ratio from 20:1 to 15:1.
18. The composition according to claim 5 , wherein said gelatinized or pregelatinized starch is in an amount from 20 to 35% by weight.